JP2022531012A5 - - Google Patents
Info
- Publication number
- JP2022531012A5 JP2022531012A5 JP2021565743A JP2021565743A JP2022531012A5 JP 2022531012 A5 JP2022531012 A5 JP 2022531012A5 JP 2021565743 A JP2021565743 A JP 2021565743A JP 2021565743 A JP2021565743 A JP 2021565743A JP 2022531012 A5 JP2022531012 A5 JP 2022531012A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- copolymer
- form according
- methacrylic acid
- methyl methacrylate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962843184P | 2019-05-03 | 2019-05-03 | |
| US62/843,184 | 2019-05-03 | ||
| PCT/US2020/031174 WO2020227151A1 (en) | 2019-05-03 | 2020-05-01 | Compositions comprising indigo and/or an indigo derivative and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022531012A JP2022531012A (ja) | 2022-07-05 |
| JP2022531012A5 true JP2022531012A5 (cg-RX-API-DMAC7.html) | 2023-05-30 |
Family
ID=70775588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021565743A Pending JP2022531012A (ja) | 2019-05-03 | 2020-05-01 | インジゴ及び/又はインジゴ誘導体を含む組成物並びにその使用の方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20200345645A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3962458A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022531012A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220044435A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114340600A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020269379A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3136081A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021013386A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202106296A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020227151A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021174024A1 (en) | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| TWI836752B (zh) | 2021-11-30 | 2024-03-21 | 美商安督奎斯特機器人公司 | 用於機器人控制醫療裝置的力傳輸系統 |
| WO2023170714A1 (en) * | 2022-03-10 | 2023-09-14 | Joy Vadakkan Thomas | A topical herbal composition for fungal infection, scaling, foot cracking, eczema and dry skin diseases |
| KR20250069676A (ko) * | 2022-10-10 | 2025-05-19 | 더데르마 상하이 컴퍼니 리미티드 | 궤양 예방 및/또는 치료를 위한 스틸벤 유도체의 용도 |
| WO2025008784A1 (en) * | 2023-07-04 | 2025-01-09 | Glenmark Life Sciences Limited | Solid dispersions of tapinarof and a process for the preparation thereof |
| CN121337758A (zh) * | 2025-11-26 | 2026-01-16 | 河北省中医院(河北中医药大学第一附属医院、河北省青少年儿童脊柱侧弯防控中心) | 一种可降解的肠道药物靶向释放胶囊及制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686105A (en) | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| US7582670B2 (en) * | 2001-12-13 | 2009-09-01 | Natrogen Therapeutics, Inc. | Methods of treating an inflammatory-related disease |
| JP2013103899A (ja) * | 2011-11-11 | 2013-05-30 | Fuji Chem Ind Co Ltd | 難溶性薬物の新規な固体分散体 |
| JP6382187B2 (ja) * | 2012-06-21 | 2018-08-29 | フォスフォレックス,インコーポレーテッド | インジルビンのナノ微粒子、その誘導体およびそれらを作製しかつ利用する方法 |
| TWI615157B (zh) * | 2013-02-06 | 2018-02-21 | 大塚製藥股份有限公司 | 包括不定形西洛他唑的固體分散劑 |
| JP2017500343A (ja) * | 2013-12-20 | 2017-01-05 | フォスフォレックス,インコーポレーテッド | インジルビン固体分散体組成物 |
| TWI737602B (zh) | 2015-04-09 | 2021-09-01 | 瑞士商高德美公司 | 藥學組合物及其製劑 |
| CA3021071A1 (en) * | 2016-04-19 | 2017-10-26 | Ferring B.V. | Oral pharmaceutical compositions of mesalazine |
| WO2019142799A1 (ja) * | 2018-01-18 | 2019-07-25 | 学校法人慶應義塾 | 潰瘍性大腸炎治療カプセル剤 |
-
2020
- 2020-05-01 WO PCT/US2020/031174 patent/WO2020227151A1/en not_active Ceased
- 2020-05-01 CN CN202080042143.2A patent/CN114340600A/zh active Pending
- 2020-05-01 KR KR1020217039676A patent/KR20220044435A/ko not_active Withdrawn
- 2020-05-01 CA CA3136081A patent/CA3136081A1/en active Pending
- 2020-05-01 US US16/865,183 patent/US20200345645A1/en not_active Abandoned
- 2020-05-01 MX MX2021013386A patent/MX2021013386A/es unknown
- 2020-05-01 TW TW109114724A patent/TW202106296A/zh unknown
- 2020-05-01 AU AU2020269379A patent/AU2020269379A1/en not_active Abandoned
- 2020-05-01 JP JP2021565743A patent/JP2022531012A/ja active Pending
- 2020-05-01 EP EP20727107.3A patent/EP3962458A1/en not_active Withdrawn
-
2022
- 2022-04-22 US US17/727,510 patent/US20220249382A1/en not_active Abandoned
-
2025
- 2025-02-14 US US19/053,798 patent/US20250255820A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT9020054A1 (cg-RX-API-DMAC7.html) | ||
| JP2024506595A5 (cg-RX-API-DMAC7.html) | ||
| JP2017128614A5 (cg-RX-API-DMAC7.html) | ||
| JP2016006108A5 (cg-RX-API-DMAC7.html) | ||
| EP2205279B1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| JP2011500552A (ja) | 胃腸障害を処置するための医薬用組み合わせおよび組成物 | |
| RU2018137359A (ru) | Пероральные фармацевтические композиции месалазина | |
| CN104114163A (zh) | 治疗心血管疾病的方法 | |
| IL303767A (en) | Pharmaceutical formulations of centrapadin, and methods for its preparation and use | |
| JP2019513800A5 (cg-RX-API-DMAC7.html) | ||
| CN101721385B (zh) | 一种美沙拉嗪口服控释药物组合物 | |
| JP2007507491A (ja) | 徐放性製剤 | |
| WO2010090371A1 (en) | Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process | |
| KR20070069105A (ko) | 서방성 제제 | |
| US20150140089A1 (en) | Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity | |
| US20090028944A1 (en) | Pharmaceutical compositions comprising mesalamine | |
| US20220273619A1 (en) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolylglycyl-l-tyrosinate and methods for preparing the same | |
| US20180360764A1 (en) | Delayed sustained release pharmaceutical compositions | |
| JP2007530492A5 (cg-RX-API-DMAC7.html) | ||
| RU2018137323A (ru) | Пероральные фармацевтические композиции никотинамида | |
| JP2019513801A5 (cg-RX-API-DMAC7.html) | ||
| CN110035751A (zh) | 一种维利帕尼缓控释药物组合物及其用途 | |
| WO2017093444A1 (en) | Compositions for oral administration in the treatment of inflammatory bowel disease | |
| JPH10231242A (ja) | 持続性ジクロフェナクナトリウム組成物 | |
| WO2016072748A1 (en) | Pharmaceutical compositions comprising lobeglitazone for oral administration |